VAN SCOYOC ASSOCIATES for SMITHS GROUP
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Public Law No. 114-113, Consolidated Appropriations Act, FY2016, Chemical and biological counter measures H.R.5293/S.3000, Department of Defense Appropriations Act, FY2017, Chemical and biological counter measures
Foreign entity interest: The foreign entity, Smiths Group PLC, has the same interest in the legislative outcome of item #16 as Smiths Group.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN F KELLY | — |
| LAUREN LIPIN | — |
Budget/Appropriations BUD
Public Law No. 114-113, Consolidated Appropriations Act, FY2016, Chemical and biological counter measures H.R.5293/S.3000, Department of Defense Appropriations Act, FY2017, Chemical and biological counter measures H.R.5634/S.3001, Department of Homeland Security Appropriations Act, FY2017, Transportation Security Administration (TSA) funding H.R.5325, Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, FY2017, and Zika Response and Preparedness Act, generally
Foreign entity interest: The foreign entity, Smiths Group PLC, has the same interest in the legislative outcome of item #16 as Smiths Group.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN F KELLY | — |
| LAUREN LIPIN | — |
Homeland Security HOM
H.R.5634,/S.3001, Department of Homeland Security Appropriations Act, FY2017, Transportation Security Administration (TSA) funding
Foreign entity interest: The foreign entity, Smiths Group PLC, has the same interest in the legislative outcome of item #16 as Smiths Group.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN F KELLY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.